Skip to content
AwardedPRTGoodsFramework agreement€1,866,720

2024/0900 - DOLUTEGRAVIR + ABACAVIR + LAMIVUDINA [50 MG + 600 MG + 300 MG CÁP/COMP]

Published
Published 7 July 2026

Overview

Unidade Local de Saúde Santa Maria has procured a fixed-dose combination pharmaceutical product containing dolutegravir, abacavir, and lamivudine (50 mg + 600 mg + 300 mg capsules/tablets) for an estimated value of €1,866,720. The contract was awarded to VIIVHIV HEALTHCARE, UNIPESSOAL, LDA on 24 April 2026.

Key details

Country
PRT
Status
Awarded
Category
Goods
Estimated value
€1,866,720
Procedure
Selective
Contract type
Framework agreement
Published
7 July 2026
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
€1,866,720
Award date
24 April 2026
Contract period
— → 18 February 2027
Winner
  • VIIVHIV HEALTHCARE, UNIPESSOAL, LDA

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    7 July 2026

Contracting authority

  • Unidade Local de Saúde Santa Maria, E.P.E.

    Procuring entity

    Lisboa, PRT

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: 2024/0900 - DOLUTEGRAVIR + ABACAVIR + LAMIVUDINA [50 MG + 600 MG + 300 MG CÁP/COMP] — won by VIIVHIV HEALTHCARE, UNIPESSOAL, LDA — Skim